alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### UNITED STATES of America, Plaintiff-Appellee, v. William Woodrow SPRINGFIELD, Sr., Defendant-Appellant.

No. 16-30229

United States Court of Appeals, Ninth Circuit.

Submitted October 2, 2017 * Seattle, Washington

Filed October 20, 2017

Lori Anne Harper Suek, Leif Johnson, Assistant U.S. Attorneys, Office of the US Attorney, Billings, MT, for Plaintiff-Appellee

Joslyn Michelle Hunt, FDMT-Federal Defenders of Montana (Helena), Helena, MT, for Defendant-Appellant

Before: WARDLAW, CLIFTON, and OWENS, Circuit Judges.

*

 The panel unanimously concludes this case is suitable for decision without oral argument. *See*Fed. R. App. P. 34(a)(2).

MEMORANDUM **

Defendant William Springfield appeals from the district court’s denial of his motion to suppress. We affirm.

Even if Springfield has standing to challenge the search of the vehicle, the motion to suppress the evidence obtained through that search was properly denied. The district court found that the search of the car would have occurred anyway, even if Springfield had not been arrested and searched. That finding was not clearly erroneous. The officers testified that an inventory search of a stolen vehicle was standard procedure. *See United States v. Mota,*982 F.2d 1384, 1387 (9th Cir. 1993). It is not disputed that the vehicle had been reported stolen. Because the methamphetamine “ultimately or inevitably would have been discovered by lawful means,” the inevitable discovery doctrine applies. *Nix v. Williams,*467 U.S. 431, 444, 104 S.Ct. 2501, 81 L.Ed.2d 377 (1984).

AFFIRMED.

**

 This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 9
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM DECEMBER 31,
1998 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          MAR-31-1998
<PERIOD-START>                             APR-01-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                          42,855
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                 3,938
<INVESTMENTS-HELD-FOR-SALE>                    836,076
<INVESTMENTS-CARRYING>                           1,428
<INVESTMENTS-MARKET>                             1,434
<LOANS>                                      1,972,409
<ALLOWANCE>                                     26,097
<TOTAL-ASSETS>                               2,957,345
<DEPOSITS>                                   1,815,059
<SHORT-TERM>                                         0
<LIABILITIES-OTHER>                            906,373
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           199
<OTHER-SE>                                     235,759
<TOTAL-LIABILITIES-AND-EQUITY>               2,957,345
<INTEREST-LOAN>                                109,346
<INTEREST-INVEST>                               46,018
<INTEREST-OTHER>                                     0
<INTEREST-TOTAL>                               155,364
<INTEREST-DEPOSIT>                              60,105
<INTEREST-EXPENSE>                              39,426
<INTEREST-INCOME-NET>                           55,833
<LOAN-LOSSES>                                    3,020
<SECURITIES-GAINS>                                 258
<EXPENSE-OTHER>                                 40,870
<INCOME-PRETAX>                                 23,389
<INCOME-PRE-EXTRAORDINARY>                      23,389
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    13,388
<EPS-PRIMARY>                                        1
<EPS-DILUTED>                                        1
<YIELD-ACTUAL>                                    7.22
<LOANS-NON>                                     12,931
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                13,732
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                26,002
<CHARGE-OFFS>                                    2,935
<RECOVERIES>                                        10
<ALLOWANCE-CLOSE>                               26,097
<ALLOWANCE-DOMESTIC>                            26,097
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0
        

</TABLE>
Jonathon Ashley WILLINGHAM v. Kristen Robbins WILLINGHAM

2150927

Court of Civil Appeals of Alabama.

April 28, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
<PAGE>   1
                                                                    Exhibit 21.1

                       Pivotal Corporation - Subsidiaries

<TABLE>
<CAPTION>

                                                                    Jurisdiction of
                                                                    incorporation or
                         Name of Subsidiary                           organization
                         ------------------                         ----------------

<S>                                                                 <C>

Pivotal Corporation                                                 Washington

Pivotal Corporation Limited                                         U.K.

Pivotal Corporation France S.A. (formerly Transitif S.A.)           France

Exactium Ltd. (formerly Arad Systems Ltd.)                          Israel

Exactium Inc.                                                       Delaware

590813 British Columbia Ltd.                                        British Columbia

590822 British Columbia Ltd.                                        British Columbia

Pivotal Corporation Ireland                                         Ireland

Pivotal Technologies Corporation Limited                            Ireland

Pivotal Corporation (N.I.) Limited                                  Northern Ireland

Pivotal GmbH                                                        Germany

Simba Technologies Inc.                                             British Columbia

Simba Technologies Inc.                                             Washington State

Pivotal Corporation Australia Pty. Ltd.                             Australia
</TABLE>
<Page>

                                                                   EXHIBIT 32.01

                           SECTION 1350 CERTIFICATION

In connection with this quarterly report of ML JWH Strategic Allocation Fund
L.P. (the "Company") on Form 10-Q for the period ended March 31, 2005 as filed
with the Securities and Exchange Commission on the date hereof (this "Report"),
I, Robert M. Alderman, Chief Executive Officer, President and Manager of the
Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant of the
Sarbanes-Oxley Act of 2002, that:

1. This Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

2. The information contained in this Report fairly presents, in all material
respects, the financial condition and results of operations of of the Company.

Date: May 16, 2005
------------------

By /s/ ROBERT M. ALDERMAN
   ----------------------
Robert M. Alderman
Chief Executive Officer, President and Manager
(Principal Executive Officer)
**Exhibit 32.1**

 

**CERTIFICATIONPURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with the Quarterly Report ofDepomed, Inc. (the “Company”) on Form 10-Q for the period endingSeptember 30, 2007 as filed with the Securities and Exchange Commission on thedate hereof (the “Report”), I, Carl A. Pelzel, Chief Executive Officer of theCompany, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 ofthe Sarbanes-Oxley Act of 2002, that:

 

(1)  TheReport fully complies with the requirements of section 13(a) or15(d) of the Securities Exchange Act of 1934; and

 

(2)  Theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.

 
|   | Date: November 8,  2007  |
|--------|--------------------------|
|   |                     |
|   |                     |
|   | /s/ Carl A.  Pelzel      |   |
|   | Carl A. Pelzel           |
|   | President and            |
|   | Chief Executive  Officer |

 

 

 

----
#### UNITED STATES of America, Plaintiff-Appellee v. Richard GARZA, Defendant-Appellant

No. 16-41470 Summary Calendar

United States Court of Appeals, Fifth Circuit.

Filed August 22, 2017

Carmen Castillo Mitchell, Assistant U.S. Attorney, U.S. Attorney’s Office, Southern District of Texas, Houston, TX, for Plaintiff-Appellee

Mario Barajas, Pro Se

Before HIGGINBOTHAM, JONES, and SMITH, Circuit Judges.

PER CURIAM: *

The attorney appointed to represent Richard Garza has moved for leave to withdraw and has filed a brief in accordance with *Anders v. California,*386 U.S. 738, 87 S.Ct. 1396, 18 L.Ed.2d 493 (1967), and *United States v. Flores,*632 F.3d 229 (6th Cir. 2011). Garza has not filed a response, We have reviewed counsel’s brief and the relevant portions of the record reflected therein. We concur with counsel’s assessment that the appeal presents no nonfrivolous issue for appellate review. Accordingly, counsel’s motion for leave to withdraw is GRANTED, counsel is excused from further responsibilities herein, and the APPEAL IS DISMISSED. *See*5th Cir. R. 42.2.

*

 Pursuant to 5th Cir. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5th Cir. R. 47.5.4.
#### Charles Leland *versus*Esek Bussey.

*Oct. term*1827.

Assumpsit. The damages demanded in this action ex ceeded 100 dollars. In the Court of Common Pleas the plaintiff had judgment for 33 dollars. The defendant appealed, and in this Court the plaintiff obtained a verdict for 17 dollars. *Held,*that the plaintiff was entitled to costs to the amount of one quarter part of the damages recovered.

See *Godfrey*v. *Godfrey,*1 Pick. 236.
# Úradný vestník C 11A/2014

| | ISSN 1977-1037
  doi:10.3000/19771037.CA2014.011.slo |
| --- | --- |
| Úradný vestník
  Európskej únie | C 11A |
| | |
| Slovenské vydanie | Informácie a oznámenia | Zväzok 5715. januára 2014 |

ISSN 1977-1037

doi:10.3000/19771037.CA2014.011.slo

Úradný vestník

Európskej únie

C 11A

Slovenské vydanie

Informácie a oznámenia

Zväzok 5715. januára 2014

---

| Číslo oznamu | Obsah | Strana |
| --- | --- | --- |
| | Korigendá |
| 2014/C 011A/01 | Korigendum k oznámeniu o voľnom pracovnom mieste na pozíciu výkonného riaditeľa Európskej železničnej agentúry (ERA) vo Francúzsku (Dočasný zamestnanec – platová trieda AD 14) – COM/2014/10345 (Ú. v. EÚ C 6 A, 10.1.2014) | 1 |

Číslo oznamu

Obsah

Strana

Korigendá

2014/C 011A/01

Korigendum k oznámeniu o voľnom pracovnom mieste na pozíciu výkonného riaditeľa Európskej železničnej agentúry (ERA) vo Francúzsku (Dočasný zamestnanec – platová trieda AD 14) – COM/2014/10345 (Ú. v. EÚ C 6 A, 10.1.2014)

(Ú. v. EÚ C 6 A, 10.1.2014)

1

PREHĽAD VÝBEROVÝCH KONANÍ v Ú. v. EÚ C A

Pripojený je zoznam Ú. v. EÚ C A, ktoré boli vydané počas tohto roku.

Ak nie je uvedené inak, Ú. v. EÚ vyšli vo všetkých jazykoch.

| 5 | |
| --- | --- |
| 6 | |
| 11 | |

5

6

11

| SK | |
| --- | --- |

SK

---

Korigendá

| 15.1.2014 | SK | Úradný vestník Európskej únie | CA 11/1 |
| --- | --- | --- | --- |

15.1.2014

SK

Úradný vestník Európskej únie

CA 11/1

---

Korigendum k oznámeniu o voľnom pracovnom mieste na pozíciu výkonného riaditeľa Európskej železničnej agentúry (ERA) vo Francúzsku

(Dočasný zamestnanec – platová trieda AD 14)

COM/2014/10345

(
  Úradný vestník Európskej únie C 6 A z 10. januára 2014
  )

(2014/C 11 A/01)

Na strane 4 v časti „Postup pri podávaní prihlášky“ adresa webovej stránky v treťom odseku má znieť takto:

„https://ec.europa.eu/dgs/human-resources/seniormanagementvacancies/“.

---
<Page>

                                                                   Exhibit 99.1


                            CERTIFICATE PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

   The undersigned, Eleanor L. Thomas, President (chief executive officer) of
the managing owner, Prudential Securities Futures Management Inc. (the
"Managing Owner"), of Prudential Securities Strategic Trust (the "Trust"),
hereby certifies, pursuant to 18 U.S.C. 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that:

   (1) The Trust's Quarterly Report on Form 10-Q for the period ending
   June 30, 2002, as filed with the Securities and Exchange Commission on the
   date hereof (the "Quarterly Report"), fully complies with the requirements
   of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

   (2) The information contained in the Quarterly Report fairly presents, in
   all material respects, the financial condition and results of operations of
   the Trust.


/s/ Eleanor L. Thomas
_________________________
Eleanor L. Thomas
President (chief executive officer) of the Managing Owner
August 14, 2002



   The undersigned, Steven Weinreb, Chief Financial Officer of the managing
owner, the Managing Owner, of the Trust, hereby certifies, pursuant to
18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, that:

   (1) The Trust's Quarterly Report fully complies with the requirements of
   Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

   (2) The information contained in the Quarterly Report fairly presents, in
   all material respects, the financial condition and results of operations of
   the Trust.


/s/ Steven Weinreb
_________________________
Steven Weinreb
Chief Financial Officer of the Managing Owner
August 14, 2002
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration [Docket No. DEA-966]
 AGENCY: Drug Enforcement Administration, Justice.
 ACTION: Notice of application.
 SUMMARY: S&B Pharma LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
 DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 26, 2022. Such persons may also file a written request for a hearing on the application on or before April 26, 2022.
 ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.


SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on December 24, 2021, S&B Pharma LLC, 405 South Motor Avenue, Azusa, California 91702, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): Controlled substance
Drug code
ScheduleGamma Hydroxybutyric Acid
2010
IMarihuana
7360
ITetrahydrocannabinols
7370
IAmphetamine
1100
IIMethamphetamine
1105
IILisdexamfetamine
1205
IIMethylphenidate
1724
IIPentobarbital
2270
II4-Anilino-N-Phenethyl-4-Piperidine (ANPP)
8333
IITapentadol
9780
IIFentanyl
9801
II
 The company plans to bulk manufacture the listed controlled substances for the internal use intermediates for formulation and analytical development purposes or for sale to its customers. In reference to dug codes 7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration. Matthew J. Strait, Deputy Assistant Administrator.


[FR Doc. 2022-04062 Filed 2-24-22; 8:45 am] BILLING CODE 4410-09-P
#### SECURE AXCESS, LLC, Appellant v. EMC CORPORATION, RSA Security LLC, Appellees

2016-1354

United States Court of Appeals, Federal Circuit.

Date February 21, 2017

Andrew J. Wright, Bruster PLLC, Southlake, TX, argued for appellant. Also represented by Anthony Kyle Bruster; Eric M. Albritton, Albritton Law Firm, Longview, TX; Andre J. Bahou, Secure Axcess, LLC, Plano, TX; Gregory J. Gon-salves, Falls Church, VA.

William F. Lee, Wilmer Cutler Pickering Hale and Dorr LLP, Boston, MA, argued for appellees. Also represented by Peter M. Dichiara, Mark Christopher Fleming, Cynthia D. Vreeland; Thomas A. Brown, Paul T. Dacier, Krishnendu Gupta, EMC Corporation, Hopkington, MA.

(Lourie, Plager, and Taranto, Circuit Judges).

JUDGMENT

Per Curiam

This Cause having been heard and considered, it is Ordered and Adjudged:

AFFIRMED. *See*Fed. Cir. R. 36.
#### Clifford Scott EATON Plaintiff-Appellant v. UNITED STATES of America Defendant-Appellee

No. 17-1128

United States Court of Appeals, Eighth Circuit.

Submitted: August 29, 2017

Filed: September 14, 2017

Clifford Scott Eaton, Pro Se

Jamie Goss Dempsey, Assistant U.S. Attorney, U.S. Attorney’s Office, Eastern District of Arkansas, Little Rock, AR, for Defendant-Appellee

Before LOKEN, GRUENDER, and SHEPHERD, Circuit Judges.

PER CURIAM.

Federal inmate Clifford Eaton appeals after the district court1 adversely granted summary judgment in his action under the Federal Tort Claims Act.

After careful *de novo*review of the summary judgment decision, *see Johnson v. Blaukat,*453 F.3d 1108, 1112 (8th Cir. 2006) (standard of review), we affirm for the reasons stated by the district court. *See*8th Cir. R. 47B.

1

. The Honorable Kristine G. Baker, United States District Judge for the Eastern District of Arkansas, adopting the report and recommendations of the Honorable Beth Deere, United States Magistrate Judge for the Eastern District of Arkansas.
#### UNITED STATES of America, Plaintiff-Appellee, v. Jose Israel LOPEZ-DIAZ, Defendant-Appellant.

No. 16-50263

United States Court of Appeals, Ninth Circuit.

Submitted June 26, 2017*

Filed July 3, 2017

Daniel Earl Zipp, Assistant U.S. Attorney, Helen H. Hong, Assistant U.S. Attorney, Office of the US Attorney, San Diego, CA, for Plaintiff-Appellee

Sarah Marie Gorman, Trial Attorney, Law Offices Of Sarah M, Gorman, San Diego, CA, for Defendant-Appellant

Before: PAEZ, BEA, and MURGUIA, Circuit Judges.

*

 The panel unanimously concludes this case is suitable for decision without oral argument. See Fed. R, App. P. 34(a)(2).

MEMORANDUM **

Jose Israel Lopez-Diaz appeals from the district court’s judgment and challenges the 57-month sentence imposed upon remand following his guilty-plea conviction for importation of methamphetamine, in violation of 21 U.S.C. §§ 952 and 960. We have jurisdiction under 28 U.S.C. § 1291, and we affirm.

In 2014, Lopez-Diaz appealed the district court’s denial of a minor role adjustment under U.S.S.G. § 3B1.2. This court vacated Lopez-Diaz’s sentence and remanded for resentencing in light of the 2015 amendment to the minor role Guideline. On remand, the district court considered the five factors enumerated in the amendment and again denied a minor role adjustment. Lopez-Diaz now appeals, arguing that the court incorrectly interpreted and inadequately considered the five factors. We review the district court’s interpretation of the Guidelines de novo. *See United States v. Quintero-Leyva,*823 F.3d 519, 522 (9th Cir. 2016).

The record reflects that the court fully considered and properly applied to Lopez-Diaz’s case each of the five factors. The court also conducted the required comparative analysis between Lopez-Diaz and his co-participants, and evaluated whether Lopez-Diaz was “substantially less culpable than the average participant” in light of *569the totality of the circumstances. *See*U.S.S.G. § 3B1.2 cmt. n.3(A), (C); *Quintero-Leyva,*823 F.3d at 523. The court did not err in evaluating Lopez-Diaz’s entitlement to a minor role reduction under the amended Guideline.

Lopez-Diaz also argues that the 57-month sentence is substantively unreasonable. The district court did not abuse its discretion. *See Gall v. United States,*552 U.S. 38, 51, 128 S.Ct. 586, 169 L.Ed.2d 445 (2007). The below-Guidelines1 sentence is substantively reasonable in light of the 18 U.S.C. § 3553(a) factors and the totality of the circumstances. *See Gall,*552 U.S. at 51, 128 S.Ct. 586.

AFFIRMED.

**

 This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3.

1

. Although the district court calculated the Guidelines range as 57-71 months, the correctly calculated range was 70-87 months. Lopez-Diaz did not object to this miscalculation in the district court, nor does he raise it on appeal. Because the error favored Lopez-Diaz, we see no reason to remand. *See United States v. Dallman,*533 F.3d 755, 761-62 (9th Cir. 2008) (describing plain error standard).